A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiation Therapy (WBRT) for Resected Metastatic Brain Disease
RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumour and
cause less damage to normal tissue. Radiation therapy uses high-energy x rays to kill tumour
cells. It is not yet known whether stereotactic radiosurgery is more effective than
whole-brain radiation therapy in treating patients with brain metastases that have been
removed by surgery.
PURPOSE: This randomized phase III trial studies how well stereotactic radiosurgery works
compared to whole-brain radiation therapy in treating patients with brain metastases that
have been removed by surgery.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society